Prostate cancer
Results
Phase 3
This trial looked at a new drug called MDV3100 for prostate cancer that had got worse despite hormone therapy and chemotherapy.
Recruitment start: 1 September 2009
Recruitment end: 15 November 2010
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Prof Johann de Bono
Astellas
Medivation
Last reviewed: 22 March 2012
CRUK internal database number: 5969